GlaxoSmithKline
GSK
#211
Rank
โ‚ฌ83.99 B
Marketcap
41,41ย โ‚ฌ
Share price
2.41%
Change (1 day)
28.08%
Change (1 year)

Revenue for GlaxoSmithKline (GSK)

Revenue in 2025 (TTM): โ‚ฌ37.85 Billion

According to GlaxoSmithKline's latest financial reports the company's current revenue (TTM ) is โ‚ฌ36.22 Billion. In 2024 the company made a revenue of โ‚ฌ38.61 Billion an increase over the revenue in the year 2023 that were of โ‚ฌ34.28 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for GlaxoSmithKline from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ37.85 B-1.95%
2024 โ‚ฌ38.61 B12.62%
2023 โ‚ฌ34.28 B3.56%
2022 โ‚ฌ33.10 B-6.47%
2021 โ‚ฌ35.39 B-0.61%
2020 โ‚ฌ35.61 B-7.42%
2019 โ‚ฌ38.46 B7.99%
2018 โ‚ฌ35.62 B7.89%
2017 โ‚ฌ33.01 B-5.61%
2016 โ‚ฌ34.97 B5.78%
2015 โ‚ฌ33.06 B6.8%
2014 โ‚ฌ30.96 B2.23%
2013 โ‚ฌ30.28 B-5.24%
2012 โ‚ฌ31.96 B-4.1%
2011 โ‚ฌ33.32 B1.4%
2010 โ‚ฌ32.87 B5.24%
2009 โ‚ฌ31.23 B0.03%
2008 โ‚ฌ31.22 B0.33%
2007 โ‚ฌ31.12 B-4.24%
2006 โ‚ฌ32.50 B-0.18%
2005 โ‚ฌ32.55 B17.24%
2004 โ‚ฌ27.77 B-2.25%
2003 โ‚ฌ28.41 B-8.62%
2002 โ‚ฌ31.08 B-7.05%
2001 โ‚ฌ33.44 B15.08%
2000 โ‚ฌ29.06 B108.91%
1999 โ‚ฌ13.91 B23.28%
1998 โ‚ฌ11.28 B3.3%
1997 โ‚ฌ10.92 B-19.73%
1996 โ‚ฌ13.60 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
AstraZeneca
AZN
โ‚ฌ49.71 B 37.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
โ‚ฌ53.70 B 48.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ54.94 B 51.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ48.21 B 33.10%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
โ‚ฌ40.64 B 12.21%๐Ÿ‡ซ๐Ÿ‡ท France
Teva Pharmaceutical Industries
TEVA
โ‚ฌ14.34 B-60.39%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Dynavax Technologies
DVAX
โ‚ฌ0.28 B-99.22%๐Ÿ‡บ๐Ÿ‡ธ USA